Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
source: pixabay.com

Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers

While novel treatments have been rapidly emerging onto the drug scene, new treatment options for pancreatic cancer have fallen behind. But now, according to OncLive’s interview with Dr. P.A. Philip,…

Continue Reading Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
source: pixabay.com

A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer

According to EMJ, findings from an analysis spanning 20 years has found that weight loss surgery used to address obesity also significantly lowers a person's risk of developing pancreatic cancer.…

Continue Reading A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
Source: Pixabay

GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

According to OncLive, Oncolytics Biotech and Roche are pairing up to run a new German Phase ½ clinical trial. The GOBLET trial will evaluate pelareorep in conjunction with atezolizumab (Tecentriq)…

Continue Reading GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
Six Grants From the FDA Will Help Fund Critical Rare Disease Clinical Trials
source: pixabay.com

Six Grants From the FDA Will Help Fund Critical Rare Disease Clinical Trials

According to a story from BioSpace, the US Food and Drug Administration (FDA) recently announced that it has awarded grant funding that will go towards six clinical trials that will…

Continue Reading Six Grants From the FDA Will Help Fund Critical Rare Disease Clinical Trials
The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
source: pixabay.com

The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic

 The United States FDA has just announced that they will be providing  6 new grants, which are worth 16 million dollars for rare disease research. These grants will last a…

Continue Reading The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
source: pixabay.com

Scientists Screen for Pancreatic Cancer Using Artificial Intelligence

  News-Medical Life Sciences recently interviewed Dr. Ananya Malhotra, Research Fellow at the London School of Hygiene, regarding her most current research involving pancreatic cancer. Dr. Malhotra believes artificial intelligence (AI)…

Continue Reading Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
Questions for COVID-19: Should Cancer Patients Attend Appointments?
Photo by National Cancer Institute on Unsplash

Questions for COVID-19: Should Cancer Patients Attend Appointments?

  In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?
Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
source: pixabay.com

Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“

  The ASCO Post recently reported findings of high response rates and improved survival from the combination of platinum-based cisplatin and gemcitabine (chemotherapy) in BRCA/PALB2 mutation positive pancreatic ductal adenocarcinoma. The goal…

Continue Reading Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“